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ABSTRACT 
 
 
Venous thromboembolism (VTE) is a common complication in orthopaedic surgery 
patients. Malaysian Clinical Practice Guidelines (CPG) on Prevention and Treatment 
of Venous Thromboembolism (2013) has recommended both enoxaparin and 
fondaparinux as the VTE prophylaxis. Although many studies had been conducted to 
evaluate the safety and efficacy of fondaparinux as VTE prophylaxis, there is no study 
ever conducted in Malaysia to determine the efficacy and safety of fondaparinux 
against enoxaparin among orthopaedic patients. Furthermore, the genetic diversity 
between patients in Malaysia and in overseas may limit the generalizability of the 
previous study’s findings. The objective of this study was to evaluate the efficacy and 
safety of fondaparinux against enoxaparin as VTE prevention among patients 
undergoing orthopaedic surgery in Hospital Selayang. This study was conducted 
retrospectively by examining electronic medical records of all patients receiving either 
fondaparinux or enoxaparin as a VTE prophylaxis for orthopaedic surgery in Hospital 
Selayang from 1
st
 January until 31
st
 December 2015. A total of 99 patients in 
enoxaparin group and 38 patients in fondaparinux group were included in the study. 
There were 3 cases of VTE observed in enoxaparin group, while no VTE incidence 
was observed in fondaparinux group. The number of major bleeding events detected 
was 42 cases (42.4%) in enoxaparin group and 13 cases (34.2%) in fondaparinux 
group. No association was found between these two groups for VTE and major 
bleeding incidences (p = 0.56 and 0.38 respectively). Variable associated with VTE 
incidence was obesity (p=0.02). While independent predictor for major bleeding 
incidence was the timing start of propylaxis (p=0.01). When adjusted for confounders 
like timing start of prophylaxis and concomitant antiplatelet, the number of concurrent 
medication also had a significant relationship with major bleeding (p=0.037). In 
conclusion, fondaparinux had similar efficacy and safety profiles with enoxaparin in 
preventing VTE in orthopaedic surgery patients. VTE incidence following orthopaedic 
surgery was associated with obesity, while major bleeding incidence was influenced 
by the timing start of VTE prophylaxis. The number of concurrent medication was 
also a significant contributor to major bleeding, when adjusted for other confounders.  
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